Haque S et al. Curr Treat Options in Rheum 2018; Advance online publication. doi: 10.1007/s40674-018-0099-x
Gout as a risk factor for osteoporosis: Epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals
This first population-based epidemiologic study supports the hypothesis that compared with individuals without gout; those with gout have a modest increase in the risk of developing osteoporosis in future [read more]. Kok VC et al. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4375-2
The authors explore the hypothesis that early life experiences may induce stress reactions and other responses that modify DNA methylation patterns and consequently influence the risk of osteoporosis in later life.
Riancho JA, Brennan-Olsen SL. Clinic Rev Bone Miner Metab 2017;15:59-68. doi:10.1007/s12018-017-9229-5
Studying the prevalence of osteoporosis in USA, Wright et al found that 16% of men and 29.9% of women over 50 years of age have the condition based on National Bone Health Alliance diagnostic criteria.
Wright NC et al. Osteoporos Int 2017;28:1225–1232. doi:10.1007/s00198-016-3865-3
This chapter explores the epidemiology of osteoporosis and fragility fracture, cell biology and biomechanics, and the latest research on global trends in age- and sex-specific fracture rates.
Moon RJ, Cooper C, Harvey NC. In: The Duration and Safety of Osteoporosis Treatment. Edited by Silverman S, Abrahamsen B. Springer International Publishing Switzerland, 2016. doi:10.1007/978-3-319-23639-1_1